Improved care for patients with type 2 diabetes and schizophrenia
Approx. 43.000 people in Denmark suffer from schizophrenia, and it is estimated that type 2 diabetes (T2D) occurs 2-3 times more often within this group compared with the rest of the Danish population.
The frequency of T2D is a result of lifestyle, reduced understanding of the disease, medical treatment and genetics. Research shows a significant excess mortality with this group of patients, and they live on average 15-20 years less than the population in general.
AIM
The project is an explorative study based on the research design Participatory Design, and it aims to investigate if a new health technology solution can improve diabetes care for patients with schizophrenia and T2D.
The purpose is to clarify the diabetic and schizophrenic patients’ need for care in close cooperation with the patients, relatives and health professionals to improve care for the patients across sectors.
The project will contribute with extensive knowledge of the patient groups experiences and their needs in relation to diabetes care across sectors. This will create an understanding of how to develop interventions to meet the patients’ needs by actively involving those who are usually excluded.
DATE
Start: 2020
End: 2023
PARTNERS
The project is rooted in Steno Diabetes Centre Odense.
EXTERNAL FUNDING
The project is partially funded by the fund Psykiatriens Forksningsfond in the Region of Southern Denmark.
";}{:}{:gb}a:1:{i:0;s:76:"";}{:}
